{"id":60329,"date":"2024-11-13T10:05:06","date_gmt":"2024-11-13T09:05:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/"},"modified":"2024-11-13T10:05:06","modified_gmt":"2024-11-13T09:05:06","slug":"vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/","title":{"rendered":"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nLong term manufacturing partnership \u2013 builds on previous product development partnership<\/li>\n<li>\nVIVOLTA to be exclusive electrospun component manufacturer to Neurochase<\/li>\n<li>\nAddresses growing neurological disorders market<\/li>\n<\/ul>\n<p>WAALRE, Netherlands&#8211;(BUSINESS WIRE)&#8211;VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Neurochase, the CNS (central nervous system) delivery platform specialist, to manufacture electrospun micro-catheters to deliver advanced therapies to the brain.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/4\/Vivolta_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/22\/Vivolta_logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/4\/Vivolta_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/21\/Vivolta_logo.jpg\"><\/a><\/p>\n<p>\nUK-based Neurochase is a medical technology company developing a scalable system to deliver therapies by Convection Enhanced Delivery (CED), directly to specific targets in the brain and CNS.<\/p>\n<p>\nThis technique allows drugs to get through the blood brain barrier to deep brain structures via micro-catheters; at the tip of the catheter a pressure gradient is generated and pushes the drug through the interstitial space allowing for homogenous distribution and maximising the therapeutic effect.<\/p>\n<p>\nVIVOLTA first partnered with Neurochase in 2022 to jointly develop the electrospun component of Neurochase\u2019s micro-catheter delivery system. VIVOLTA has worked as part of Neurochase\u2019s R&amp;D team, bringing a wealth of material science and application development expertise helping to achieve the breakthrough performance of the micro-catheter, and differentiating Neurochase\u2019s product from other devices.<\/p>\n<p>\nVIVOLTA will be Neurochase\u2019s exclusive component manufacturer based on its unparalleled ability to manufacture electrospun medical products at scale using their fully-automated MediSpin\u2122 production system.<\/p>\n<p>\nAlmost one billion people suffer from neurological disorders in the US and Europe alone, with the cost of care amounting to US$1.6 trillion per year. CED drug delivery is currently being used in clinical trials to treat a range of neurological conditions, including Parkinson\u2019s Disease, Huntington\u2019s Diseases, brain tumours and Fronto Temporal Dementia. Neurochase plans on entering clinical trials with its micro-catheter delivery system in collaboration with its clients in 2025.<\/p>\n<p>\n<b>Denis Leissing, CEO of VIVOLTA<\/b> said:<\/p>\n<p>\n<i>\u201cThis partnership builds on our already successful product development work with Neurochase, establishing a long term manufacturing relationship. It is a great example of our full suite of electrospinning solutions from product development to commercial manufacturing. We\u2019re proud that our team\u2019s expertise along with our unique and scalable MediSpin<\/i>\u2122<i> manufacturing system will help bring this high-performance micro-catheter to patients who will benefit.\u201d<\/i><\/p>\n<p>\n<b>Sharon Kane, CEO of Neurochase <\/b>added:<\/p>\n<p>\n<i>\u201cThe VIVOLTA relationship has been hugely important in finding a solution to one of the most technically challenging components of the Neurochase delivery system. We are excited to be taking our transformative product forward together into large scale manufacture with such a knowledgeable, skilled and motivated team.\u201d<\/i><\/p>\n<p>\n<b>About VIVOLTA<\/b><\/p>\n<p>\nVIVOLTA is a fully integrated medical electrospinning solutions provider devoted to the development and high-volume manufacturing of electrospun medical products.<\/p>\n<p>\n<b>About Neurochase<\/b><\/p>\n<p>\nNeurochase is developing the next generation of CNS delivery platforms, together with providing specialist services to pharmaceutical and biotech companies, enabling them to deliver gene and other therapies.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>VIVOLTA<\/b><br \/>Denis Leissing, CEO<br \/>\n<br \/><b>+31 40 2827 956<\/b><\/p>\n<p>\n<b>V<\/b><b>igo Consulting (Media enquiries)<\/b><br \/>Rozi Morris<br \/>\n<br \/><b>+44 20 7390 0230<\/b><br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#58;&#118;&#105;&#118;olta&#x40;&#x76;&#x69;&#x67;&#x6f;&#x63;&#111;&#110;&#115;&#117;&#108;tin&#x67;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">v&#105;&#x76;&#x6f;&#x6c;t&#97;&#x40;&#x76;&#x69;g&#111;&#x63;&#x6f;&#x6e;s&#117;&#x6c;&#x74;&#x69;n&#103;&#x2e;&#x63;&#x6f;m<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Long term manufacturing partnership \u2013 builds on previous product development partnership VIVOLTA to be exclusive electrospun component manufacturer to Neurochase Addresses growing neurological disorders market WAALRE, Netherlands&#8211;(BUSINESS WIRE)&#8211;VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Neurochase, the CNS (central nervous system) delivery platform specialist, to manufacture electrospun micro-catheters to deliver advanced &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60329","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Long term manufacturing partnership \u2013 builds on previous product development partnership VIVOLTA to be exclusive electrospun component manufacturer to Neurochase Addresses growing neurological disorders market WAALRE, Netherlands&#8211;(BUSINESS WIRE)&#8211;VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Neurochase, the CNS (central nervous system) delivery platform specialist, to manufacture electrospun micro-catheters to deliver advanced ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-13T09:05:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/22\/Vivolta_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain\",\"datePublished\":\"2024-11-13T09:05:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/\"},\"wordCount\":493,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241113171774\\\/en\\\/2302353\\\/22\\\/Vivolta_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/\",\"name\":\"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241113171774\\\/en\\\/2302353\\\/22\\\/Vivolta_logo.jpg\",\"datePublished\":\"2024-11-13T09:05:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241113171774\\\/en\\\/2302353\\\/22\\\/Vivolta_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241113171774\\\/en\\\/2302353\\\/22\\\/Vivolta_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/","og_locale":"en_US","og_type":"article","og_title":"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain - Pharma Trend","og_description":"Long term manufacturing partnership \u2013 builds on previous product development partnership VIVOLTA to be exclusive electrospun component manufacturer to Neurochase Addresses growing neurological disorders market WAALRE, Netherlands&#8211;(BUSINESS WIRE)&#8211;VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Neurochase, the CNS (central nervous system) delivery platform specialist, to manufacture electrospun micro-catheters to deliver advanced ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/","og_site_name":"Pharma Trend","article_published_time":"2024-11-13T09:05:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/22\/Vivolta_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain","datePublished":"2024-11-13T09:05:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/"},"wordCount":493,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/22\/Vivolta_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/","url":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/","name":"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/22\/Vivolta_logo.jpg","datePublished":"2024-11-13T09:05:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/22\/Vivolta_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20241113171774\/en\/2302353\/22\/Vivolta_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vivolta-partners-with-neurochase-to-manufacture-electrospun-micro-catheters-delivering-advanced-cns-therapies-to-the-brain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60329"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60329\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}